People | June 06, 2022
APhA appoints Ilisa Bernstein Interim CEO
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Dr. Bernstein will tap into her decades of leadership and strategy experience as she transitions into this new role at APhA
Susanne Kaestner joins the company as Senior Vice President, Quality and member of the Executive Team, and Dr. Thea Boehm as Vice President, Business Development.
PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
The DCGI has already approved Covovax for restricted use in emergency situations in adults on December 28th 2021
The guidance also urges companies to act quickly to initiate a recall when public health is at risk and to do so prior to completing an investigation into the cause of the problem
Boehringer Ingelheim plans to study this novel investigational therapy in patients with progressive fibrosing interstitial lung diseases
The recommendation has been sent to the DCGI for approval
Pfizer and Moderna are also working on vaccines that target the Omicron variant
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
Subscribe To Our Newsletter & Stay Updated
